Akanda (NASDAQ:AKAN) Upgraded to Sell at Wall Street Zen

Akanda (NASDAQ:AKAN) was upgraded by Wall Street Zen to a “sell” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings downgraded Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Akanda currently has a consensus rating of “Sell”.

Akanda Stock Up 0.4%

Shares of AKAN opened at $21.99 on Friday. The stock has a 50 day moving average of $13.41 and a 200 day moving average of $12.17. Akanda has a 12 month low of $2.30 and a 12 month high of $209.02.

Akanda Company Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.